JAK inhibition ameliorates bone destruction by simultaneously targeting mature osteoclasts and their precursors

Yari, Shinya; Kikuta, Junichi; Shigyo, Hotaka; Miyamoto, Yu; Okuzaki, Daisuke; Furusawa, Yuki; Minoshima, Masafumi; Kikuchi, Kazuya; Ishii, Masaru

doi:https://doi.org/10.1186/s41232-023-00268-4

JAK inhibition ameliorates bone destruction by simultaneously targeting mature osteoclasts and their precursors

Yari, Shinya; Kikuta, Junichi; Shigyo, Hotaka et al.

Inflammation and Regeneration, 2023, 43(1), 18

アクセス数:1,368件（2025-07-18 10:17 集計）

固定URL: https://hdl.handle.net/11094/93151

閲覧可能ファイル

ファイル	フォーマット	利用条件	サイズ	閲覧回数	利用開始日	説明	information
InflammRegen_43_1	pdf	なし	5.32 MB	120	2023.11.17

Creative Commons : 表示

論文情報

ファイル出力 EndNote Basic出力 Mendeley出力

タイトル	JAK inhibition ameliorates bone destruction by simultaneously targeting mature osteoclasts and their precursors
著者	著者名 Yari, Shinya
	NRID 1000060710069 1000060710069 researchmap permalink jkikuta jkikuta Scopus Author ID 36637603800 36637603800 著者名 Kikuta, Junichi
	著者名 Shigyo, Hotaka
	NRID 1000090965336 1000090965336 researchmap permalink yumiyamoto yumiyamoto ORCID 0000-0002-2715-6465 0000-0002-2715-6465 著者名 Miyamoto, Yu
	NRID 1000000346131 1000000346131 ORCID 0000-0002-4552-783X 0000-0002-4552-783X researchmap permalink read0092307 read0092307 Scopus Author ID 6506703054 6506703054 著者名 Okuzaki, Daisuke
	著者名 Furusawa, Yuki
	NRID 1000020600844 1000020600844 ORCID 0000-0002-9352-3454 0000-0002-9352-3454 researchmap permalink cbatgcm_m33 cbatgcm_m33 Scopus Author ID 12774750700 12774750700 著者名 Minoshima, Masafumi
	NRID 1000070292951 1000070292951 researchmap permalink kikuchilab315 kikuchilab315 Scopus Author ID 7404088901 7404088901 著者名 Kikuchi, Kazuya
	NRID 1000010324758 1000010324758 researchmap permalink read0076684 read0076684 Scopus Author ID 35074093500 35074093500 著者名 Ishii, Masaru
キーワード等	Cell migration
	Chemokine
	Inflammatory bone destruction
	Intravital imaging
	JAK inhibitor
	Osteoclast
内容	Yari S., Kikuta J., Shigyo H., et al. JAK inhibition ameliorates bone destruction by simultaneously targeting mature osteoclasts and their precursors. Inflammation and Regeneration 43, 18 (2023); https://doi.org/10.1186/s41232-023-00268-4.
抄録	Background: Rheumatoid arthritis (RA) is characterized by chronic inflammation and resultant cartilage/bone destruction because of aberrantly activated osteoclasts. Recently, novel treatments with several Janus kinase (JAK) inhibitors have been shown to successfully ameliorate arthritis-related inflammation and bone erosion, although their mechanisms of action for limiting bone destruction remain unclear. Here, we examined the effects of a JAK inhibitor on mature osteoclasts and their precursors by intravital multiphoton imaging. Methods: Inflammatory bone destruction was induced by local injection of lipopolysaccharides into transgenic mice carrying reporters for mature osteoclasts or their precursors. Mice were treated with the JAK inhibitor, ABT-317, which selectively inhibits the activation of JAK1, and then subjected to intravital imaging with multiphoton microscopy. We also used RNA sequencing (RNA-Seq) analysis to investigate the molecular mechanism underlying the effects of the JAK inhibitor on osteoclasts. Results: The JAK inhibitor, ABT-317, suppressed bone resorption by blocking the function of mature osteoclasts and by targeting the migratory behaviors of osteoclast precursors to the bone surface. Further exhaustive RNA-Seq analysis demonstrated that Ccr1 expression on osteoclast precursors was suppressed in the JAK inhibitor-treated mice; the CCR1 antagonist, J-113863, altered the migratory behaviors of osteoclast precursors, which led to the inhibition of bone destruction under inflammatory conditions. Conclusions: This is the first study to determine the pharmacological actions by which a JAK inhibitor blocks bone destruction under inflammatory conditions; this inhibition is beneficial because of its dual effects on both mature osteoclasts and immature osteoclast precursors.
出版者	BioMed Central Ltd
収録物名	Inflammation and Regeneration
巻(号)	43(1)
ページ	18
刊行年月	2023-03-03
言語	英語
ハンドルURL	https://hdl.handle.net/11094/93151
eISSN	18808190
関連情報 (isIdenticalTo)	DOI (出版社版) https://doi.org/10.1186/s41232-023-00268-4
アクセス権	open access
権利情報	This article is licensed under a Creative Commons Attribution 4.0 International License.
出版タイプ	Version of Record
カテゴリ	学術雑誌論文 Journal Article

資源タイプ	学術雑誌論文
ローカル資源タイプ	学術雑誌論文
DCMI資源タイプ	text
DCTERMS.bibliographicCitation	Inflammation and Regeneration. 2023, 43(1), p. 18
DC.title	JAK inhibition ameliorates bone destruction by simultaneously targeting mature osteoclasts and their precursors
DC.creator	Yari, Shinya
	Kikuta, Junichi
	Shigyo, Hotaka
	Miyamoto, Yu
	Okuzaki, Daisuke
	Furusawa, Yuki
	Minoshima, Masafumi
	Kikuchi, Kazuya
	Ishii, Masaru
DC.publisher	BioMed Central Ltd
DC.language' scheme='DCTERMS.RFC1766	英語
DC.type' scheme='DCTERMS.DCMIType	text
DCTERMS.issued' scheme='DCTERMS.W3CDTF	2023-03-03
DC.identifier	https://doi.org/10.1186/s41232-023-00268-4
DC.subject	Cell migration
	Chemokine
	Inflammatory bone destruction
	Intravital imaging
	JAK inhibitor
	Osteoclast
DC.description	Yari S., Kikuta J., Shigyo H., et al. JAK inhibition ameliorates bone destruction by simultaneously targeting mature osteoclasts and their precursors. Inflammation and Regeneration 43, 18 (2023); https://doi.org/10.1186/s41232-023-00268-4.
DCTERMS.abstract	Background: Rheumatoid arthritis (RA) is characterized by chronic inflammation and resultant cartilage/bone destruction because of aberrantly activated osteoclasts. Recently, novel treatments with several Janus kinase (JAK) inhibitors have been shown to successfully ameliorate arthritis-related inflammation and bone erosion, although their mechanisms of action for limiting bone destruction remain unclear. Here, we examined the effects of a JAK inhibitor on mature osteoclasts and their precursors by intravital multiphoton imaging. Methods: Inflammatory bone destruction was induced by local injection of lipopolysaccharides into transgenic mice carrying reporters for mature osteoclasts or their precursors. Mice were treated with the JAK inhibitor, ABT-317, which selectively inhibits the activation of JAK1, and then subjected to intravital imaging with multiphoton microscopy. We also used RNA sequencing (RNA-Seq) analysis to investigate the molecular mechanism underlying the effects of the JAK inhibitor on osteoclasts. Results: The JAK inhibitor, ABT-317, suppressed bone resorption by blocking the function of mature osteoclasts and by targeting the migratory behaviors of osteoclast precursors to the bone surface. Further exhaustive RNA-Seq analysis demonstrated that Ccr1 expression on osteoclast precursors was suppressed in the JAK inhibitor-treated mice; the CCR1 antagonist, J-113863, altered the migratory behaviors of osteoclast precursors, which led to the inhibition of bone destruction under inflammatory conditions. Conclusions: This is the first study to determine the pharmacological actions by which a JAK inhibitor blocks bone destruction under inflammatory conditions; this inhibition is beneficial because of its dual effects on both mature osteoclasts and immature osteoclast precursors.
DC.rights	This article is licensed under a Creative Commons Attribution 4.0 International License.
DC.format	93151
citation_title	JAK inhibition ameliorates bone destruction by simultaneously targeting mature osteoclasts and their precursors
citation_author	Yari, Shinya
	Kikuta, Junichi
	Shigyo, Hotaka
	Miyamoto, Yu
	Okuzaki, Daisuke
	Furusawa, Yuki
	Minoshima, Masafumi
	Kikuchi, Kazuya
	Ishii, Masaru
citation_publisher	BioMed Central Ltd
citation_language	英語
citation_date	2023-03-03
citation_journal_title	Inflammation and Regeneration
citation_volume	43
citation_issue	1
citation_firstpage	18
citation_doi	https://doi.org/10.1186/s41232-023-00268-4
citation_public_url	https://hdl.handle.net/11094/93151

JAK inhibition ameliorates bone destruction by simultaneously targeting mature osteoclasts and their precursors

閲覧可能ファイル

論文情報

論文詳細を表示